Comparative Analysis of the Effects of Packaging Signal, Transgene Orientation, Promoters, Polyadenylation Signals, and E3 Region on Growth Properties of First-Generation Adenoviruses
- 10 July 2003
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 14 (10), 1017-1034
- https://doi.org/10.1089/104303403766682278
Abstract
First-generation adenovectors have been developed for gene therapy and vaccine applications. The construction of these adenovectors has entailed the use of numerous types of expression cassettes. It has long been known that first-generation adenovectors can be rescued more easily and to higher titers with some transgenes than with others. This study has systematically shown that there can be marked differences in growth properties of recombinant adenovectors attributable to the use of promoters, the orientation of the transgene within the E1A/E1B-deleted region, and the inclusion of the E3 region. In addition, we had demonstrated the benefit of extending the packaging signal region to include elements V, VI, and VII. The effects of the complete packaging region were studied by plasmid competition studies between original and modified adenovectors. Similar competition studies between E3+ and E3- adenovectors were performed and showed that the E3+ vector had a growth advantage over its E3- counterpart. By making various changes, we have enhanced the growth capacity of our recombinant adenovector by more than 3-fold under serum-free and cell suspension growth conditions. Along with this enhanced growth, our adenovectors have maintained their genetic stability after 21 successive passages in cell culture. This increased robustness will be critical when adapting first-generation recombinant adenovectors to commercial production.Keywords
This publication has 48 references indexed in Scilit:
- The Canine Factor VIII 3′-Untranslated Region and a Concatemeric Hepatocyte Nuclear Factor 1 Regulatory Element Enhance Factor VIII Transgene ExpressionIn VivoHuman Gene Therapy, 2002
- Hexon Gene Switch Strategy for the Generation of Chimeric Recombinant AdenovirusHuman Gene Therapy, 2002
- Differential influence of the E4 adenoviral genes on viral and cellular promotersThe Journal of Gene Medicine, 2000
- New Helper Cells and Matched Early Region 1-Deleted Adenovirus Vectors Prevent Generation of Replication-Competent AdenovirusesHuman Gene Therapy, 1998
- Analytical Anion-Exchange HPLC of Recombinant Type-5 Adenoviral ParticlesHuman Gene Therapy, 1997
- Adenovirus genes that modulate the sensitivity of virus‐infected cells to lysis by TNFJournal of Cellular Biochemistry, 1993
- Efficient Transfection and Expression of Heterologous Genes in PC12 CellsDNA and Cell Biology, 1990
- Tissue–Specific Activity of Heterologous Viral Promoters in Primary Rat Hepatocytes and Hep G2 CellsHepatology, 1989
- Definition of an efficient synthetic poly(A) site.Genes & Development, 1989
- Studies on transformation of Escherichia coli with plasmidsJournal of Molecular Biology, 1983